Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 214 entries
View as:

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00573404 Org: User:
Start: 07/31/07 End: 03/31/11 Due: 03/31/12

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897468 Org: User:
Start: 02/28/07 End: 05/31/18 Due: 05/31/19

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Phase: N/A Priority: Normal
NCT ID: NCT00544336 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00544648 Org: User:
Start: 11/30/07 End: 04/30/14 Due: 04/30/15

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00949052 Org: User:
Start: 01/31/09 End: 02/28/18 Due: 02/28/19

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01850108 Org: User:
Start: 05/31/13 End: 12/31/24 Due: 12/31/25

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Phase: N/A Priority: Normal
NCT ID: NCT06701214 Org: User:
Start: 10/28/20 End: 11/30/31 Due: 11/30/32

Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00574145 Org: User:
Start: 02/28/07 End: 04/30/09 Due: 04/30/10

Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03652233 Org: User:
Start: 11/02/18 End: 11/30/22 Due: 11/30/23

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00471718 Org: User:
Start: 01/31/04 End: 08/31/09 Due: 08/31/10

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00900523 Org: User:
Start: 11/30/06 End: 07/31/08 Due: 07/31/09

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897650 Org: User:
Start: 12/31/05 End: 07/31/17 Due: 07/31/18

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00930930 Org: User:
Start: 06/30/09 End: 10/31/14 Due: 10/31/15

Metabolism Informed Smoking Treatment: The MIST RCT

Phase: N/A Priority: Normal
NCT ID: NCT04590404 Org: User:
Start: 11/17/20 End: 11/22/24 Due: 11/22/25

Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT06638398 Org: User:
Start: 10/31/24 End: 12/01/27 Due: 12/01/28

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02860039 Org: User:
Start: 09/30/16 End: 09/30/24 Due: 09/30/25

Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00984490 Org: User:
Start: 09/30/09 End: 07/31/11 Due: 07/31/12

Pain Control in Hospice Patients With Cancer-Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT00609297 Org: User:
Start: 07/31/07 End: 05/31/11 Due: 05/31/12

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00651716 Org: User:
Start: 12/31/06 End: 10/31/19 Due: 10/31/20

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898664 Org: User:
Start: 06/30/06 End: 04/30/08 Due: 04/30/09

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00416650 Org: User:
Start: 07/31/02 End: 03/31/13 Due: 03/31/14

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05770531 Org: User:
Start: 08/04/23 End: 10/01/28 Due: 10/01/29

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01205815 Org: User:
Start: 06/03/10 End: 08/31/25 Due: 08/31/26

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Phase: N/A Priority: Normal
NCT ID: NCT00503776 Org: User:
Start: 01/31/06 End: 08/31/08 Due: 08/31/09

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT02448225 Org: User:
Start: 06/16/15 End: 10/10/22 Due: 10/10/23